Please login to the form below

Not currently logged in
Email:
Password:

AVEO appoints Nikhil Mehta as its senior VP, regulatory and quality assurance

He joins the biopharma from Tang Capital Management

AVEO Oncology has appointed Dr Nikhil Mehta as senior vice president or regulatory and quality assurance, a role that will see him oversee all aspects of regulatory, quality and technical operations for the company’s portfolio.

Dr Mehta brings over 25 years’ experience in biotechnology and pharmaceutical industries to AVEO and most recently, Dr Mehta served as executive vice president and chief regulatory strategies at Tang Capital Management, where he was involved in establishing two biopharmaceutical companies.

Prior to Tang Capital, he served as global head of regulatory affairs at Baxalta and before that, he was vice president, global regulatory affairs, oncology, haematology, immunology and diagnostics at Merck & Co.

He has also held roles for Shire, Bristol-Myers Squibb and Hoffman-La Roche.

Michael Baily, president and chief executive officer, AVEO, said: “Dr Mehta brings to AVEO a depth of experience in regulatory affairs and oncology that we believe will be invaluable as we plan and advance our US registration strategy for tivozanib as a potential treatment for renal cell carcinoma.”

“I anticipate Dr Mehta’s integration into the AVEO team will be seamless and rapidly productive and we look forward to working with him.”

11th December 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics